Moderna, Inc.
MRNA
#416
Rank
$59.750 B
Marketcap
United States
Country
$149.66
Share price
147.09%
Change (1 day)
472.18%
Change (1 year)
Categories
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus;…
Key Metrics
Trailing P/E
—
Forward P/E
-35.37
EPS (TTM)
$-8.66
Forward EPS
$-4.47
Price / Book
9.33
EV / EBITDA
-27.0x
Beta
1.11
Dividend Yield
—
Return on Equity
-39.00%
Return on Assets
-13.26%
Debt / Equity
19.04
Current Ratio
2.29
Gross Margin
-66.02%
Operating Margin
-557.93%
Net Profit Margin
-141.43%
Free Cash Flow
$299.250M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 17
-9.35%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$1.922B
Latest Net Income$-2,822,000,000
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Moderna, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
MRNA
No recent news available. Set FINNHUB_API_KEY to enable news.
